Market closed

Metagenomi/$MGX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Metagenomi

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Ticker

$MGX
Trading on

Industry

Biotechnology

Employees

207

Metagenomi Metrics

BasicAdvanced
$152M
Market cap
-
P/E ratio
-$3.01
EPS
-
Beta
-
Dividend rate
$152M
$12.74
$1.61
3.4M
6.178
6.057
16.177
18.013
-14.85%
-30.34%
1.805
0.59
0.59
-0.922
45.13%
-83.87%

What the Analysts think about Metagenomi

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Metagenomi stock.

Metagenomi Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Metagenomi Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MGX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Metagenomi stock?

Metagenomi (MGX) has a market cap of $152M as of December 22, 2024.

What is the P/E ratio for Metagenomi stock?

The price to earnings (P/E) ratio for Metagenomi (MGX) stock is 0 as of December 22, 2024.

Does Metagenomi stock pay dividends?

No, Metagenomi (MGX) stock does not pay dividends to its shareholders as of December 22, 2024.

When is the next Metagenomi dividend payment date?

Metagenomi (MGX) stock does not pay dividends to its shareholders.

What is the beta indicator for Metagenomi?

Metagenomi (MGX) does not currently have a Beta indicator.